TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

Published

MALVERN, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference.

TELA’s management is scheduled to present at Piper Sandler’s 35th Annual Healthcare Conference at 11:00 am ET on November 30th, 2023. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor ContactGreg Chodaczek347-620-7010ir@telabio.com    

 

Primary Logo

Source: TELA Bio, Inc.

In This Story

TELA